Ranbaxy and Daiichi Sankyo Company Limited have announced the reconstitution of Ranbaxy’s Board of Directors. The composition of the new Board reflects the new ownership structure at Ranbaxy following Daiichi Sankyo’s strategic investment completed in November 2008. Daiichi Sankyo now holds 63.92% of the equity share capital of Ranbaxy.
The detailed news can be viewed by our privileged readers from linking into this site
The detailed news can be viewed by our privileged readers from linking into this site
No comments:
Post a Comment